ERBB2 CNG was also seen in patients with anal cancer, carcinoma unknown primary, cervical cancer, melanoma, neuroendocrine cancer, renal cell carcinoma, and salivary gland cancer (n = 1 for each). This evidence concerns the gene ERBB2 and cervical carcinoma.